Omnicare Agrees To Pay $15.3 Million To Resolve Allegations of Violations at Long-Term Care Facilities

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Omnicare Agrees To Pay $15.3 Million To Resolve Allegations of Violations at Long-Term Care Facilities

DEA: Firm Improperly Handled Emergency Medications, Failed To Follow Oral Prescription Mandates

Dennis Tosh

June 8, 2020 at 17:21:10 ET

Omnicare Inc. agreed to enter into a $15.3 million civil settlement with the federal government to resolve allegations that the company violated the Controlled Substances Act (CSA) by, among other things, dispensing opioids and other controlled substances on an emergency basis to residents of long-term care facilities (LTCFs) without valid prescriptions. The settlement was announce... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Omnicare Agrees To Pay $15.3 Million To Resolve Allegations of Violations at Long-Term Care Facilities

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT